Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.91 CNY | -1.92% |
|
-6.38% | +1.65% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 14.01x | 2.62x | 0.68x | 0.58x | 4.59x | 7.58x | 4.93% | 3.08B | |
| 18.45x | 1.63x | 2.3x | 0.79x | 12.42x | 13.33x | -.--% | 16B | |
| 24.15x | 2.72x | 3.15x | 0.97x | 16.36x | 16.67x | 0.93% | 7.44B | |
| 15.82x | 1.66x | 1.72x | 0.71x | 7.36x | 9.25x | 2.36% | 6.03B | |
| 14.13x | 2.15x | 0.8x | 0.92x | 6.63x | 8.68x | 3% | 4.06B | |
| 14.7x | 4.96x | 6.95x | 1.29x | 7.88x | 14.78x | 5.4% | 3.32B | |
| 14.9x | 6.74x | 2.28x | 0.9x | 6.77x | 9.42x | 4.3% | 3.1B | |
| 39.51x | - | 1.26x | - | - | - | - | 2.56B | |
| 21.46x | 3.76x | 0.93x | 0.62x | 7.96x | 13.02x | 1.91% | 1.58B | |
| -112.57x | 2.76x | 1.62x | 0.45x | 16.46x | 71.51x | 0.02% | 1.52B | |
| 12.12x | 0.86x | 0.12x | 0.29x | 2.79x | 5.75x | 4.19% | 963M | |
| 14.75x | 2.44x | -0.56x | 0.86x | 6.99x | 15.03x | 5.66% | 934M | |
| 40.37x | 3.85x | -6.2x | 0.94x | 11.78x | 23.2x | - | 872M | |
| 26.14x | 7.13x | 0.97x | 0.95x | 12.9x | 20x | 1.37% | 801M | |
| 13.73x | 1.85x | 1.13x | 0.66x | 8.15x | 13.15x | 0.38% | 693M | |
| Average | 11.44x | 3.22x | 1.14x | 0.78x | 9.22x | 17.24x | 2.65% | 3.53B | |
| Weighted average by Cap. | 15.51x | 2.66x | 2.06x | 0.82x | 10.44x | 14.37x | 1.89% |
Select your edition
All financial news and data tailored to specific country editions
